US Stock MarketDetailed Quotes

ANEB Anebulo Pharmaceuticals

Watchlist

2.850
-0.150-5.00%

Close Apr 18 16:00 ET

73.91MMarket Cap-6951P/E (TTM)

Anebulo Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q2)Dec 31, 2023

(Q1)Sep 30, 2023

(FY)Jun 30, 2023

(Q4)Jun 30, 2023

(Q3)Mar 31, 2023

(Q2)Dec 31, 2022

(Q1)Sep 30, 2022

(FY)Jun 30, 2022

(Q4)Jun 30, 2022

(Q3)Mar 31, 2022

Total revenue

Operating revenue

--0

Cost of revenue

Gross profit

Operating expense

-27.61%2.76M

-2.62%2.54M

72.50%11.78M

7.26%2.49M

52.37%2.86M

255.99%3.81M

67.99%2.61M

89.03%6.83M

-6.41%2.33M

240.43%1.88M

Selling and administrative expenses

-12.63%1.7M

-8.27%1.27M

59.79%6.18M

-10.78%1.08M

84.04%1.77M

126.43%1.94M

65.30%1.39M

187.97%3.87M

78.07%1.21M

245.51%964.28K

-General and administrative expense

-12.63%1.7M

-8.27%1.27M

59.79%6.18M

-10.78%1.08M

84.04%1.77M

126.43%1.94M

65.30%1.39M

187.97%3.87M

78.07%1.21M

245.51%964.28K

Research and development costs

-43.17%1.06M

3.80%1.27M

89.10%5.6M

26.74%1.42M

19.01%1.09M

778.16%1.87M

71.13%1.22M

30.46%2.96M

-38.11%1.12M

235.25%915.36K

Operating profit

27.61%-2.76M

2.62%-2.54M

-72.50%-11.78M

-7.26%-2.49M

-52.37%-2.86M

-255.99%-3.81M

-67.99%-2.61M

-89.03%-6.83M

6.41%-2.33M

-240.43%-1.88M

Net non-operating interest income expense

395.51%43.68K

55.2K

1,160.32%92.41K

8.82K

168.22%7.33K

Non-operating interest income

756.65%75.52K

--55.2K

1,160.32%92.41K

----

--8.82K

--0

618.82%7.33K

----

Non-operating interest expense

--31.84K

----

--0

----

Other net income (expense)

97.38%-594

3,511.79%7.66K

-2,215.48%-41.15K

-1,939.17%-93.6K

1,995.46%66.07K

-1,111.66%-22.65K

-86.13%212

99.99%-1.78K

99.98%-4.59K

185.19%3.15K

Other non- operating income (expenses)

97.38%-594

3,511.79%7.66K

-2,215.48%-41.15K

-1,939.17%-93.6K

1,995.46%66.07K

-1,111.66%-22.65K

-86.13%212

-32.22%-1.78K

-144.04%-4.59K

185.19%3.15K

Income before tax

28.99%-2.72M

5.02%-2.48M

-71.89%-11.73M

-7.44%-2.5M

-49.11%-2.8M

-256.66%-3.83M

-68.14%-2.61M

77.44%-6.83M

92.02%-2.32M

-237.60%-1.88M

Income tax

Net income

28.99%-2.72M

5.02%-2.48M

-71.89%-11.73M

-7.44%-2.5M

-49.11%-2.8M

-256.66%-3.83M

-68.14%-2.61M

77.44%-6.83M

92.02%-2.32M

-237.60%-1.88M

Net income continuous Operations

28.99%-2.72M

5.02%-2.48M

-71.89%-11.73M

-7.44%-2.5M

-49.11%-2.8M

-256.66%-3.83M

-68.14%-2.61M

77.44%-6.83M

92.02%-2.32M

-237.60%-1.88M

Minority interest income

Net income attributable to the parent company

28.99%-2.72M

5.02%-2.48M

-71.89%-11.73M

-7.44%-2.5M

-49.11%-2.8M

-256.66%-3.83M

-68.14%-2.61M

77.44%-6.83M

92.02%-2.32M

-237.60%-1.88M

Preferred stock dividends

Other preferred stock dividends

Net income attributable to common stockholders

28.99%-2.72M

5.02%-2.48M

-71.89%-11.73M

-7.44%-2.5M

-49.11%-2.8M

-256.66%-3.83M

-68.14%-2.61M

82.25%-6.83M

92.02%-2.32M

78.59%-1.88M

Basic earnings per share

26.67%-0.11

9.09%-0.1

-62.07%-0.47

0.00%-0.1

-37.50%-0.11

-200.00%-0.15

-57.14%-0.11

89.75%-0.29

93.71%-0.1

78.76%-0.08

Diluted earnings per share

26.67%-0.11

9.09%-0.1

-62.07%-0.47

0.00%-0.1

-37.50%-0.11

-200.00%-0.15

-57.14%-0.11

89.75%-0.29

93.71%-0.1

78.76%-0.08

Dividend per share

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q2)Dec 31, 2023	(Q1)Sep 30, 2023	(FY)Jun 30, 2023	(Q4)Jun 30, 2023	(Q3)Mar 31, 2023	(Q2)Dec 31, 2022	(Q1)Sep 30, 2022	(FY)Jun 30, 2022	(Q4)Jun 30, 2022	(Q3)Mar 31, 2022
Total revenue	0	0	0	0	0	0	0	0	0	0
Operating revenue	--0	--0	--0	--0	--0	--0	--0	--0	--0	--0
Cost of revenue
Gross profit
Operating expense	-27.61%2.76M	-2.62%2.54M	72.50%11.78M	7.26%2.49M	52.37%2.86M	255.99%3.81M	67.99%2.61M	89.03%6.83M	-6.41%2.33M	240.43%1.88M
Selling and administrative expenses	-12.63%1.7M	-8.27%1.27M	59.79%6.18M	-10.78%1.08M	84.04%1.77M	126.43%1.94M	65.30%1.39M	187.97%3.87M	78.07%1.21M	245.51%964.28K
-General and administrative expense	-12.63%1.7M	-8.27%1.27M	59.79%6.18M	-10.78%1.08M	84.04%1.77M	126.43%1.94M	65.30%1.39M	187.97%3.87M	78.07%1.21M	245.51%964.28K
Research and development costs	-43.17%1.06M	3.80%1.27M	89.10%5.6M	26.74%1.42M	19.01%1.09M	778.16%1.87M	71.13%1.22M	30.46%2.96M	-38.11%1.12M	235.25%915.36K
Operating profit	27.61%-2.76M	2.62%-2.54M	-72.50%-11.78M	-7.26%-2.49M	-52.37%-2.86M	-255.99%-3.81M	-67.99%-2.61M	-89.03%-6.83M	6.41%-2.33M	-240.43%-1.88M
Net non-operating interest income expense	395.51%43.68K	55.2K	1,160.32%92.41K			8.82K	0	168.22%7.33K
Non-operating interest income	756.65%75.52K	--55.2K	1,160.32%92.41K	----	----	--8.82K	--0	618.82%7.33K	----	----
Non-operating interest expense	--31.84K	----	----	----	----	--0	----	----	----	----
Other net income (expense)	97.38%-594	3,511.79%7.66K	-2,215.48%-41.15K	-1,939.17%-93.6K	1,995.46%66.07K	-1,111.66%-22.65K	-86.13%212	99.99%-1.78K	99.98%-4.59K	185.19%3.15K
Other non- operating income (expenses)	97.38%-594	3,511.79%7.66K	-2,215.48%-41.15K	-1,939.17%-93.6K	1,995.46%66.07K	-1,111.66%-22.65K	-86.13%212	-32.22%-1.78K	-144.04%-4.59K	185.19%3.15K
Income before tax	28.99%-2.72M	5.02%-2.48M	-71.89%-11.73M	-7.44%-2.5M	-49.11%-2.8M	-256.66%-3.83M	-68.14%-2.61M	77.44%-6.83M	92.02%-2.32M	-237.60%-1.88M
Income tax
Net income	28.99%-2.72M	5.02%-2.48M	-71.89%-11.73M	-7.44%-2.5M	-49.11%-2.8M	-256.66%-3.83M	-68.14%-2.61M	77.44%-6.83M	92.02%-2.32M	-237.60%-1.88M
Net income continuous Operations	28.99%-2.72M	5.02%-2.48M	-71.89%-11.73M	-7.44%-2.5M	-49.11%-2.8M	-256.66%-3.83M	-68.14%-2.61M	77.44%-6.83M	92.02%-2.32M	-237.60%-1.88M
Minority interest income
Net income attributable to the parent company	28.99%-2.72M	5.02%-2.48M	-71.89%-11.73M	-7.44%-2.5M	-49.11%-2.8M	-256.66%-3.83M	-68.14%-2.61M	77.44%-6.83M	92.02%-2.32M	-237.60%-1.88M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders	28.99%-2.72M	5.02%-2.48M	-71.89%-11.73M	-7.44%-2.5M	-49.11%-2.8M	-256.66%-3.83M	-68.14%-2.61M	82.25%-6.83M	92.02%-2.32M	78.59%-1.88M
Basic earnings per share	26.67%-0.11	9.09%-0.1	-62.07%-0.47	0.00%-0.1	-37.50%-0.11	-200.00%-0.15	-57.14%-0.11	89.75%-0.29	93.71%-0.1	78.76%-0.08
Diluted earnings per share	26.67%-0.11	9.09%-0.1	-62.07%-0.47	0.00%-0.1	-37.50%-0.11	-200.00%-0.15	-57.14%-0.11	89.75%-0.29	93.71%-0.1	78.76%-0.08
Dividend per share
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall